讨论
自由的追求2017-01-05 23:01
$BioSpecifics生物(BSTC)$ 瞬间跌10%多,这是在打止损吗是要大涨了查看全文
简介:Biospecifics Technologies Corp.于1990年注册于美国特拉华州,是一家生物制药公司,专注于研究可用于多种适应症的可注射胶原酶。它就可注射胶原酶(Auxilium命名其为“XIAFLEXTM”(原名“AA4500”))在腱膜挛缩症、阴茎硬结病和肩周炎(粘连性囊炎)的临床适用与Auxilium Pharmaceuticals Inc.签订了开发和许可协议。且Auxilium拥有该公司可能需要的获得其他适应症的途径,包括脂肪瘤(该公司为此已资助且授权Auxilium启动早期发育的研究)和人类及犬脂肪瘤。 目前Auxilium在美国销售XIAFLEX以用于腱膜挛缩症的治疗。
今开: | 昨收:88.53 |
最高: | 最低: |
涨停价: | 跌停价: |
总市值:650248866 |
自由的追求2017-01-05 23:01
$BioSpecifics生物(BSTC)$ 瞬间跌10%多,这是在打止损吗是要大涨了查看全文
峰雾2011-09-11 01:02
关注$BioSpecifics生物(BSTC)$,当前价$17.0。查看全文
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032972 Size: 7 KB 网页链接
$BioSpecifics生物(BSTC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-309778 Act: 34 Size: 76 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032449 Size: 7 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032448 Size: 6 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032450 Size: 6 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032451 Size: 5 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032453 Size: 6 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032454 Size: 11 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032455 Size: 7 KB 网页链接
$BioSpecifics生物(BSTC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032456 Size: 9 KB 网页链接